Merck & Co., Inc.
MRK
$92.72
-$0.47-0.50%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.20% | 3.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.20% | 3.38% | |||
| Cost of Revenue | -4.66% | 5.68% | |||
| Gross Profit | -6.67% | 2.70% | |||
| SG&A Expenses | 5.82% | -0.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.35% | 35.16% | |||
| Operating Income | 22.39% | -37.81% | |||
| Income Before Tax | 1.96% | -31.90% | |||
| Income Tax Expenses | -54.14% | 70.46% | |||
| Earnings from Continuing Operations | 18.44% | -42.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 75.00% | 33.33% | |||
| Net Income | 18.56% | -42.13% | |||
| EBIT | 22.39% | -37.81% | |||
| EBITDA | 17.15% | -31.83% | |||
| EPS Basic | 18.42% | -42.12% | |||
| Normalized Basic EPS | 14.58% | -34.91% | |||
| EPS Diluted | 18.98% | -42.06% | |||
| Normalized Diluted EPS | 14.90% | -34.83% | |||
| Average Basic Shares Outstanding | 0.12% | 0.00% | |||
| Average Diluted Shares Outstanding | -0.16% | -0.12% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.16% | 0.70% | |||
